Liwanli Innovation CoTPE:3054 57 Days Inventory is 794.35 as of Dec. 2025, which is 332% above its 10-year median of 183.68. GuruFocus rates TPE:3054 with a GF Score™ of 57/100 and a GF Value™ of NT$39.97 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Liwanli Innovation Co ranks worse than 71.07% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Liwanli Innovation Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Liwanli Innovation Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 3.30.
Liwanli Innovation Co (TPE:3054) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Liwanli Innovation Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Liwanli Innovation Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Liwanli Innovation Co Days Inventory Related Terms
Liwanli Innovation Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Liwanli Innovation Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Liwanli Innovation Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liwanli Innovation Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Liwanli Innovation Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Liwanli Innovation Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liwanli Innovation Co (TPE:3054) has a Days Inventory of 794.35 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Liwanli Innovation Co and its competitors. This is 332% above median its historical median of 183.68. Over the past decade, Liwanli Innovation Co's Days Inventory has ranged from 49.51 to 547.10. According to the industry distribution chart, Liwanli Innovation Co ranks #656 out of 923 companies in the Drug Manufacturers industry, placing it in the top 71.1%.
Is Liwanli Innovation Co's Days Inventory too high?
Liwanli Innovation Co's current Days Inventory of 794.35 is 332% above median its 10-year median of 183.68. Over the past 10 years, this metric has ranged from a low of 49.51 to a high of 547.10. The Drug Manufacturers industry median Days Inventory is 164.48. Liwanli Innovation Co's value of 794.35 is 382.9% above this industry median. Based on the distribution chart, Liwanli Innovation Co ranks #656 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Liwanli Innovation Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Liwanli Innovation Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Liwanli Innovation Co ranks #656 out of 923 companies for Days Inventory. This places Liwanli Innovation Co in the lower half of its industry. The industry median Days Inventory is 164.48. Liwanli Innovation Co's value of 794.35 is 382.9% above this benchmark. Historically, Liwanli Innovation Co's own Days Inventory has ranged from 49.51 to 547.10 over the past decade. While the company's 10-year median is 183.68 vs. the industry median of 164.48, Liwanli Innovation Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Liwanli Innovation Co's current Days Inventory of 794.35 is 382.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Liwanli Innovation Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liwanli Innovation Co's current Days Inventory is 794.35, which is 332% above median its own 10-year median of 183.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liwanli Innovation Co stock overvalued right now?
Based on GuruFocus' analysis, Liwanli Innovation Co (TPE:3054) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.97, compared to a current price of NT$63.40 — trading 58.6% above its estimated fair value. The current Days Inventory is 794.35, which is 332% above median its 10-year median of 183.68 and 382.9% above the Drug Manufacturers industry median of 164.48. Liwanli Innovation Co's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Liwanli Innovation Co (TPE:3054), the current Days Inventory is 794.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liwanli Innovation Co (TPE:3054) Overvalued in 2026?
Based on GuruFocus' analysis, Liwanli Innovation Co stock appears to be overvalued.
The current stock price of NT$63.40 is trading 58.6% above its estimated GF Value™ of NT$39.97.
GuruFocus considers Liwanli Innovation Co to be Significantly Overvalued.
Key valuation signals for TPE:3054:
Days Inventory: 794.35 (332% above median its 10-year median of 183.68)
GF Value™: NT$39.97 vs. price of NT$63.40 (58.6% above fair value)
Industry Position: 382.9% above the Drug Manufacturers median (#656 of 923)
No single metric tells the full story. See the TPE:3054 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liwanli Innovation Co Ltd is engaged in the manufacture, wholesale, and retail of electronic materials and the sales of biotech products like drug nutrient products. The reportable segments of the company are distinguished by products; the electronic department is mainly engaged in the sale and after-sales service of computer peripherals, memory and other related products; and the biotechnology department is mainly engaged in the sales of biotechnology products. Maximum revenue is generated from its Electronics department. Geographically, it generates a majority of its revenue from Taiwan, followed by other regions.
57GF Score
Get the complete analysis for TPE:3054
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3054 has been successfully added to your 
